QNCX (Quince Therapeutics) NASDAQ intraday up 182.82% to $0.39: watch strategic-review momentum
Intraday action on 10 Feb 2026 left QNCX stock trading at $0.39 on the NASDAQ after a 182.82% intraday gain. Volume surged to 894,071,772.00 shares versus an average of 2,389,237.00, driven by news the company engaged LifeSci Capital to review strategic alternatives. Quince Therapeutics, Inc. (QNCX) remains a small-cap biotech in the United States, with market cap $7,238,594.00 and EPS -1.20. We track how the strategic review, liquidity swings, and biotech sector tone link to the price move.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
